RDD Blog » vaccines

R&D Directions Insider

Archive for the ‘ vaccines ’ Category

Innovative delivery system gives boost to cancer vaccine development

Tuesday, January 25th, 2011

Development of a seal contraceptive has had a serendipitous result for one biotechnology company. Immunovaccine has begun making advances in cancer vaccine development through the use of its formulation system and DepoVax delivery technology. Cancer vaccines represent a multi-billion dollar market opportunity for pharmaceutical companies, but numerous vaccines fail clinical trials ...

Posted in cancer, clinical trials, vaccines | No Comments »

Eyes on screen! Better biological tools sought

Wednesday, November 11th, 2009

If youâ€™re a technology company specializing in high throughput screening and characterization of protein-based drugs, chances are the FDA wants to hear from you. Just call it part of the agencyâ€™s fact-finding mission. With biotech pursuits rapidly becoming a go-to option in mainstream drug development, FDA, like most in the ...

Posted in Uncategorized, drug discovery, vaccines | No Comments »

More proof of vaccine boom

Monday, October 26th, 2009

In case you missed it, the World Health Organization released a comprehensive new vaccines report late last week, its unveiling no doubt timed with the uptick in swine flu immunization campaigns around the world (read the latest on H1N1 vaccine supply shortages here.) Hereâ€™s the WHO press release on the study. ...

Posted in clinical trials, infectious diseases, vaccines | 1 Comment »

FDA OKs H1N1 vaccine

Wednesday, September 16th, 2009

The news is out: FDA has approved the new swine flu vaccine. Limited supplies are expected to arrive the first week of October, with about 45 million doses arriving around the middle of October. The vaccine will be available at up to 90,000 sites, including schools and clinics across the ...

Posted in H1N1, infectious diseases, vaccines | No Comments »

Regulatory minds meet in Philly

Tuesday, September 15th, 2009

Â The City of Brotherly Love is the site of this week's Regulatory Affairs Professionals Society'sÂ 2009 Annual Conference & Exhibition. With much change afoot these days at FDA and healthcare reform dominating the American consciousness (more on that later), it's no surprise the theme for this year's event is "Succeed in ...

Posted in Uncategorized, animals, cancer, clinical trials, vaccines | No Comments »

Progress against swine flu as Novartis begins human tests

Wednesday, August 5th, 2009

As swine flu spreads across 168 countries and territories, another company has begun testing a vaccine in humans. Novartis has begun the companyâ€™s first human tests in 6,000 people in a year-long trial in Britain, Germany, and the United States. Last month CSL Ltd., an Australian biopharmaceutical company, became the ...

Posted in H1N1, clinical trials, infectious diseases, vaccines | No Comments »

Mosquitoes deliver malaria immunity

Thursday, July 30th, 2009

Scientists may be on the right track in developing a vaccine against malaria using mosquitoes to deliver live malaria parasites through their bites. With reports showing that resistance is growing to artemisinin, the main drug used against malaria in the many areas where chloroquine is no longer effective, the need ...

Posted in clinical trials, infectious diseases, vaccines | No Comments »

Diabetes studies offer cancer clues

Thursday, June 4th, 2009

Researchers have made a breakthrough that may increase the efficiency of vaccines and cancer treatments. They discovered that diabetes drug metformin can increase T-cellâ€™s in the bodyâ€™s immune system and since T-cells can remember pathogens they have encountered from past infections of vaccinations they can fight infections faster. DiabetesÂ therapies are ...

Posted in cancer, diabetes, vaccines | No Comments »

Swine flu battle rages on

Thursday, May 28th, 2009

With the number of swine flu deaths over 100, scientists are getting closer to developing a vaccine. Companies like Sanofi Pasteur, Vical, and CSL are a few that have made headlines. Sanofi Pasteur received the new seed virus to begin production of a H1N1 vaccine. The company expects the development process ...

Posted in vaccines | No Comments »

The race is on for swine flu vaccine

Wednesday, April 29th, 2009

With the announcement of the first U.S. death from the swine flu and its spread into Germany, researchers are working hard to make a vaccine. The Associated Press reported that U.S. scientists hope to have a reference strain for the swine flu by May to ship to manufacturers to begin their ...

Posted in animals, infectious diseases, vaccines | No Comments »

©2012 UBM Canon